Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Tagatose is a functional sweetener. It is a naturally occurring monosaccharide, specifically a hexose. It is commonly found in dairy with a similar texture and sweetened capacity to sucrose but... It is approved as a food additive as a low calorie sweetener.
- Mechanism
- Curator reviewed
he steps in the metabolism of tagatose are identical to those for fructose or fruit sugar but tagatose is incompletely absorbed. Only 15-20 percent of tagatose is absorbed in the small intestine. The major part of ingested tagatose is fermented in the colon by indigenous microflora, resulting in the production of short-chain fatty acids. The short chain fatty acids are absorbed almost completely and metabolized.
- Primary indication
- Intended for use as a therapeutic adjunct in the treatment of type II diabetes.Curator reviewed
- Formula / weight
- C6H12O6 · 180.1559 g/mol (avg)
- Also known as
- D-lyxo-hexulose · D-tag · D-tagatose · keto-D-tagatose
Resolves to
BJHIKXHVCXFQLS-PQLUHFTBSA-NSMILESOC[C@@H](O)[C@H](O)[C@H](O)C(=O)COWhat you can answer from here — as of September 14, 2026
Which companies are running trials of Tagatose, in which indications and phases, and which of those programs are still active?